IJCRR - Vol 08 Issue 09, May, 2016
COMPARATIVE ANALYSIS OF SENSITIVITY AND SPECIFICITY OF CARDIAC SPECIFIC TROPONIN I AND CK-MB FOR DIAGNOSIS OF ST SEGMENT ELEVATION MYOCARDIAL INFARCTION
Author: Sandipkumar R. Patel, Hariom Sharma, Bhavika Vanani
Background: Study is designed to see correlation of cardiac specific Troponin I and Creatine Kinase-MB level to diagnose ST segment elevation myocardial infarction. Aim and Objectives: To access the diagnostic importance of cardiac specific Troponin I over Creatine Kinase-MB in patient of ST-segment elevation myocardial infarction. Materials and Methods: A comparative study was carried out in 100 patients, having ST segment elevation myocardial infarction. A group of 100 normal healthy individuals, age and sex matched from the same population served as controls. Troponin I and Creatine Kinase-MB levels were estimated in both the groups. Results: Results of present study shows that cardiac specific Troponin I and CK-MB levels were significantly higher in STEMI patients compared to healthy subjects with ‘p’ value of <0.0001. Pearson’s correlation test show positive correlation between Troponin I and CK-MB in STEMI patients. 17% of STEMI patients had normal CK-MB levels, but there Troponin I levels were elevated significantly. Conclusion: Troponin I level is more specific for confirming the diagnosis of acute myocardial infarction where CK-MB fails to do so.
Keywords: Troponin I, ST-segment elevation myocardial infarction (STEMI), Creatine Kinase – MB (CK-MB)
Sandipkumar R. Patel, Hariom Sharma, Bhavika Vanani. COMPARATIVE ANALYSIS OF SENSITIVITY AND SPECIFICITY OF CARDIAC SPECIFIC TROPONIN I AND CK-MB FOR DIAGNOSIS OF ST SEGMENT ELEVATION MYOCARDIAL INFARCTION International Journal of Current Research and Review. Vol 08 Issue 09, May, 21-25
1. Harrison’s Principles of Internal Medicine, Volume 1, 18th edition, chapter 245: ST-Segment Elevation Myocardial Infarction. McGraw Hill Education; p. 4082.
2. Sushma Pandey, Suresh Pandey, Purushottam Jhanwar, Anshul Jhanwar. A prospective study of Myocardial Infarction patients admitted in a tertiary care hospital of south-eastern Rajasthan. Int J Biol Med Res. 2012;3(2):1694-96.
3. Gary Ross, Frank N. Bever, Zi Uddin, Elaine M. Hockman. Troponin I sensitivity and specificity for the diagnosis of acute myocardial infarction. JAOA 2000;100:29-32.
4. Harper’s Illustrtaed Biochemistry, 28th Edition, chapter 7:Enzymes: Mechanism of Action, pp 127-28.
5. Jagannadha Rao Peela, Abdalla M. Jarari, Abdul Hai, Avinaash K. Rawal, Shoba Devi Kolla, Shakila Sreekumar et al. Cardiac Biomarkers: The Troponins and CK- MB. Ibnosina Journal of Medicine and Biomedical Sciences 2010;2(5):190-97.
6. Denis Xavier, Prem Pais, P J Devereaux, Changchun Xie, D Prabhakaran, K Srinath Reddy et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet 2008;371:1435–42.
7. S Joarder, M Hoque, M Towhiduzzaman, AF Salehuddin,N Islam, M Akter et al. Cardiac Troponin-I And CK-MB for Risk Stratification in Acute Myocardial Infarction (First Attack): A Comparative Study. Bangladesh J Med Biochem 2011;4(1):10- 15.
8. Allan S. Jaffe, Jan Ravkilde, Robert Roberts, Ulf Naslund, Fred S. Apple, Marcello Galvani et al. It’s Time for a Change to a Troponin Standard. Circulation 2000;102:1216-20.